Tiaki is working
to provide disease-modifying therapeutics that benefit patients with age-related dementias.
We have a
of microglia functions, and what critical functions are lost in the causes of dementia. This biological mindset will allow Tiaki to better predict microglia targets for the development of disease modifying therapeutics.